[Nitroglycerin patches: properties and norms for correct use]. 1998

E Soler Climent

The frequent application of Nitroglycerin Transdermal Systems in patients who need a prophylaxis of anginal episodes requires that medical section should know to use them and their pharmacological properties. These knowledges about their application should be explained to patients and their relatives clear and concisely for them to achieve an accurate use. Having checked the required bibliography, I want to show in this article both the characteristics of this pharmacological preparation and some important points about educational process that patients and relatives should follow: at the same time, this article tries to answer all the questions which might arise.

UI MeSH Term Description Entries
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

E Soler Climent
February 1988, European heart journal,
E Soler Climent
December 1992, Masui. The Japanese journal of anesthesiology,
E Soler Climent
June 1984, The Medical letter on drugs and therapeutics,
E Soler Climent
January 1985, Clinical pharmacy,
E Soler Climent
January 1986, Geriatric nursing (New York, N.Y.),
E Soler Climent
October 1986, Archives of internal medicine,
E Soler Climent
August 1982, American pharmacy,
E Soler Climent
September 1987, Journal of cardiovascular pharmacology,
E Soler Climent
July 1984, The American journal of cardiology,
E Soler Climent
July 1989, The Medical letter on drugs and therapeutics,
Copied contents to your clipboard!